TCL Archive Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events June 28, 2013
TCL Archive Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds November 28, 2008